Lilly's bebtelovimab receives Emergency Use Authorization fo

/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates...

Related Keywords

United States , Kevin Hern , Daniel Skovronsky , Dani Barnhizer , Eli Lilly , Vaccine Research Center , Centers For Disease , National Institute Of Allergy , Drug Administration , Clinical Worsening After Monoclonal Antibody Administration , Lilly Research Laboratories , Exchange Commission Lillyundertakes , Emergency Use Authorization , Lilly Research , Healthcare Providers , Important Safety , Including Anaphylaxis , Emergency Use , Potential Risk , National Institute , Infectious Diseases , Vaccine Research , Private Securities Litigation Reform Act , Disease Control , Eli Lilly And Company , Health Care Amp Hospitals , Biotechnology , Pharmaceuticals , Medical Pharmaceuticals , Infection Control , Fda Approval ,